Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda
2025-10-22 01:55:39 ET
More on Innovent Biologics, Takeda Pharmaceutical
- Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually
- Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call On Phase 3 Narcolepsy Type 1 Data Presented At World Sleep 2025 (Transcript)
- Trump’s 100% drug tariffs send pharma stocks lower
- Takeda names Lilly's Rhonda Pacheco as President of the U.S. unit
Read the full article on Seeking Alpha
For further details see:
Innovent inks $11.4 billion cancer drug partnership with Japan's TakedaNASDAQ: IVBXF
IVBXF Trading
-1.19% G/L:
$9.95 Last:
8,095 Volume:
$10 Open:



